EcoDrugPlus

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSCAFG00020009470
Gene Symbol: APH1B
3 Cross references
193 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSCAFG00020014377
Gene Symbol: APEX1
2 Cross references
213 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSCAFG00020010656
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSCAFG00020025191
Gene Symbol: ALOX5
3 Cross references
222 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSCAFG00020025114
Gene Symbol: ALOX5AP
3 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSCAFG00020019571
Gene Symbol: AVPR1A
3 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSCAFG00020005106
Gene Symbol: AVPR1B
3 Cross references
136 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCAFG00020022923
Gene Symbol: AVPR2
3 Cross references
251 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSCAFG00020001575
Gene Symbol: AHR
3 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSCAFG00020021922
Gene Symbol: AURKA
2 Cross references
229 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSCAFG00020026688
Gene Symbol: LOC112661601
2 Cross references
229 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSCAFG00020007090
Gene Symbol: AURKB
2 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).